Saudi Arabias industrialization policy, shaped by governmental incentives and favorable investment regulations, is significantly boosting the local pharmaceutical industry. The Saudi pharmaceutical market is the largest in the Middle East and by far the largest in the Gulf Cooperation Council. In fact, Saudi pharmaceutical sales contributed to a substantial 58% of total GCC drug sales in 2013.

  • How are public measures such as the Foreign Investment Act affecting investments in the pharmaceutical industry?

  • What is the National Plan for Science, Technology and Innovation and how will it promote biotechnology research?

  • Are there any imposed price cuts on drugs and how will they affect pharmaceutical sales?

Our report offers in-depth insight into Saudi Arabias macroeconomic environment, healthcare sector, pharmaceutical market, clinical trial industry, R&D activities, and recent business alliances & investments.

It provides you with a clear Roadmap for Business Growth based on the following proprietary tools:


EXECUTIVE SUMMARY

TABLES & GRAPHS

GLOSSARY

I.          COUNTRY OVERVIEW

II.        MACROECONOMIC & SOCIAL OUTLOOK

a.   MACROECONOMICS

b.   BUSINESS ENVIRONMENT

c.   SOCIAL OUTLOOK

III.       HEALTHCARE DEVELOPMENTS

a.   OVERVIEW

b.   PROVISION

c.   EXPENDITURE RATIOS

d.   PERSONNEL & INFRASTRUCTURE

e.   DISEASE BURDEN

IV.       MARKET ACCESS

a.   REGISTRATION

b.   PRICING & REIMBURSEMENT

V.        PHARMACEUTICAL OUTLOOK

a.   OVERVIEW

b.   PHARMACEUTICAL MARKET

c.   LEADING PHARMACEUTICAL COMPANIES

d.   MANUFACTURING & TRADE

VI.       COMPLIANCE

a.   MARKETING PRACTICES

b.   CLINICAL TRIALS

VII.     RESEARCH & DEVELOPMENT

a.   R&D FUNDS BY SOURCE

b.   PHARMA SHARE IN R&D

VIII.    CROs / CLINICAL TRIALS

IX.       ALLIANCES & INVESTMENTS

X.        CONCLUDING REMARKS

Table 1. Demographics in Saudi Arabia, 2013
Table 2. Target performance timelines to obtain marketing authorization, 2012
Table 3. Top 10 prescription drugs, 2011
Table 4. Leading pharmaceutical companies, 2013

Figure 1: GDP by economic activity, 2013
Figure 2: FDI inflows in Saudi Arabia, 2011
Figure 3: FDI inflows by sector, 2011
Figure 4: Distribution of hospitals by sector, 2013
Figure 5: Healthcare expenditures, 2012
Figure 6: Major causes of death, 2009
Figure 7: Registration process in Saudi Arabia, 2012
Figure 8: Drug market trends, 2013
Figure 9: GCC pharmaceutical sales by country, 2013
Figure 10: Production of pharmaceuticals and medicinal chemicals, 2013
Figure 11: Pharmaceutical trade, 2012
Figure 12: Pharmaceutical publications by category, 2013
Figure 13: Registered clinical trials, 2009-2013
Figure 14: Clinical trials by therapeutic area, 2013
 

Order Report

Please fill out the form below. A sales representative will
get back to you very shortly.

First Name*

E-mail Address*

Company*

Country*

Requested Report

Last Name*

Phone Number*

Position*

City*

Verification*

Details